CRISPR/cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel like factor 4-Reference-Cited by-同舟云学术

CRISPR/cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel like factor 4

Published:2021-10-26 Issue: Volume: Page:
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Weiying¹,Wang Qiang²,Du Haibo³,Jiang Shichao⁴⁵⁶

Affiliation:

1. Health Management Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China

2. Department of human resources, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China

3. Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai 201620, China

4. Department of orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China

5. Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China

6. Department of orthopedics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China

Funder

Project of Shandong medical and health science development

Academic promotion pro gramme of Shandong First Medical University

the National Science Foundation of China

Chinese Universities Scientific Fund

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1995106

Reference32 articles.

1. 1. Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014; 46:95-104.

2. 2. Zhang YL, Pu YC, Wang J, Li ZC, Wang HL. Research progress regarding the role of long non-coding RNAs in osteosarcoma. Oncol Lett 2020; 20:2606-12.

3. 3. Miller RW. Contrasting epidemiology of childhood osteosarcoma, Ewing’s tumor, and rhabdomyosarcoma. Natl Cancer Inst Monogr 1981:9-15.

4. 4. Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, et al. AKT3 is a key regulator of head and neck squamous cell carcinoma. Cancer Sci 2021; 112:2325-34.

5. 5. Suyama K, Yao JH, Liang HZ, Benard O, Loudig OD, Amgalan D, et al. An Akt3 Splice Variant Lacking the Serine 472 Phosphorylation Site Promotes Apoptosis and Suppresses Mammary Tumorigenesis. Cancer Research 2018; 78:103-14.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human disease-related long noncoding RNAs: Impact of ginsenosides;Journal of Ginseng Research;2024-07

2. KLF transcription factors in bone diseases;Journal of Cellular and Molecular Medicine;2024-03-28

3. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA;Drug Development Research;2024-03-05

4. SRY-box transcription factor 21 antisense divergent transcript 1: Regulatory roles and clinical significance in neoplastic conditions and Alzheimer's Disease;Journal of Cancer;2023

5. Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis;Bioengineered;2022-03-01